[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603236":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":27,"studyPopulation":16,"armGroups":28,"interventions":49,"overallOfficials":16,"centralContacts":60,"locations":66,"responsibleParty":86,"collaborators":16,"id":90,"slug":16,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":16,"eligibilityCriteria":95,"healthyVolunteers":96,"sex":97,"minAge":98,"maxAge":99,"enrollmentInfo":100,"targetDuration":16,"studyType":103,"phases":104,"briefSummary":106,"conditions":107,"keywords":109,"overallStatus":69,"whyStopped":16,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":123},{"fullName":5,"class":6},"University of Texas at Austin","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":16,"otherOutcomes":16},[9,13],{"measure":10,"description":11,"timeFrame":12},"Composite cognitive score in the dot-probe task","The participant pays attention to a fixation cross in the center of the screen, which is followed by the presentation of two images on the left and right of the screen. One of these new images is a \"threat\" image, while the other is neutral. Following each trial of stimuli presentation, a probe type (\"\\\u003C\" vs. \"\\>\") will randomly appear in the same location previously occupied by either the threatening or neutral image and remain on the screen until the participant has responded. Participants respond to the probe type by pressing the \"←\" or the \"→\" arrow key, respectively, on the keyboard, as quickly but as accurately as possible. The probe randomly replaces the neutral or the negative stimulus with equal frequency (50\u002F50). The single primary outcome is the composite cognitive score which is calculated on the basis of performance in this task.","Visit 1 (baseline), Visit 2 (three days after Visit 1), Visit 3 (1 week after Visit 2)",{"measure":14,"description":15,"timeFrame":12},"Change in concentration of oxygenated hemoglobin as measured by functional near-infrared spectroscopy","Hemodynamic activity is assessed non-invasively using near-infrared spectroscopy. In this procedure, a participant wears an apparatus on the head which contains an array of light sources and detectors. Light is applied to the surface of the skin, and a small fraction of the light passes through the underlying tissue and reflects back to the surface, where it is detected and the number of photons at specific light wavelengths are counted by a computer. This photon count can be converted to changes in concentration of metabolic indices, such as oxygenated\u002Fdeoxygenated hemoglobin.",null,{"allocation":18,"interventionModel":19,"interventionModelDescription":16,"primaryPurpose":20,"observationalModel":16,"timePerspective":16,"maskingInfo":21},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":22,"maskingDescription":16,"whoMasked":23},"TRIPLE",[24,25,26],"PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR","The investigators will conduct two studies: one examining the efficacy of transcranial photobiomodulation as a standalone treatment to alleviate sub-clinical anxiety symptoms and another evaluating the role of transcranial photobiomodulation as an adjunct to a form of cognitive behavioral therapy in anxiety treatment. The investigators will recruit individuals with sub-clinical anxiety and use attention bias assessment (ABA) to assess levels of anxiety, and then use attention bias modification (ABM) to reduce levels of anxiety. Brain activity will be monitored using functional near-infrared spectroscopy (fNIRS).\n\nAn online prescreen questionnaire will be used to determine participant eligibility. No medical records are accessed\u002Fobtained for verifying inclusion\u002Fexclusion criteria. Informed consent is obtained during the first in-person visit. Participants fill out questionnaires to assess their medical history and anxiety\u002Fdepression symptoms. The participants then participate in either ABA or ABA\u002FABM while wearing the fNIRS headset before and after transcranial photobiomodulation treatment or sham. Both studies will comprise three in-person visits with an online follow-up a week later. In this single-blind, sham-controlled experiment, block randomization will be performed to minimize selection bias and allocation bias.",[29,36,41,45],{"label":30,"type":31,"description":32,"interventionNames":33},"Arm 1: attention bias assessment (ABA), transcranial photobiomodulation (tPBM)","ACTIVE_COMPARATOR","Participants will receive attention bias assessment (ABA) in conjunction with active transcranial photobiomodulation (tPBM) treatment to the forehead.",[34,35],"Behavioral: Attention bias assessment and modification","Device: Transcranial photobiomodulation",{"label":37,"type":38,"description":39,"interventionNames":40},"Arm 2: attention bias assessment (ABA), sham tPBM","SHAM_COMPARATOR","Participants will receive attention bias assessment (ABA) in conjunction with sham (laser light off) transcranial photobiomodulation (tPBM) treatment to the forehead.",[34],{"label":42,"type":31,"description":43,"interventionNames":44},"Arm 3: attention bias assessment and modification (ABA\u002FABM), transcranial photobiomodulation (tPBM)","Participants will receive attention bias assessment plus attention bias modification (ABA\u002FABM) in conjunction with active transcranial photobiomodulation (tPBM) treatment to the forehead.",[34,35],{"label":46,"type":38,"description":47,"interventionNames":48},"Arm 4: attention bias assessment and modification (ABA\u002FABM), sham tPBM","Participants will receive attention bias assessment plus attention bias modification (ABA\u002FABM) in conjunction with sham (laser light off) transcranial photobiomodulation (tPBM) treatment to the forehead.",[34],[50,55],{"type":51,"name":52,"description":53,"armGroupLabels":54,"otherNames":16},"BEHAVIORAL","Attention bias assessment and modification","Attention bias assessment and modification involve two versions of the dot-probe task. These tasks are based on the premise that repeated attention shifts can retrain attentional biases, with the expectation that reducing attentional bias toward threats will alleviate sub-clinical anxiety symptoms.",[30,37,42,46],{"type":56,"name":57,"description":58,"armGroupLabels":59,"otherNames":16},"DEVICE","Transcranial photobiomodulation","Participants will receive near-infrared light at 1064 nanometers to the right side of the forehead for 8 minutes. The investigators have introduced this form of transcranial photobiomodulation (tPBM) as a means of human cognitive enhancement, and as an adjunct for attention bias modification for the reduction of symptoms of depression. In the present study, the investigators wish to extend these findings to the use of attention bias modification for the reduction of sub-clinical anxiety.",[30,42],[61],{"name":62,"role":63,"phone":64,"phoneExt":16,"email":65},"Francisco Gonzalez-Lima, Ph.D.","CONTACT","512-537-5257","utanxietystudy1@gmail.com",[67],{"facility":68,"status":69,"city":70,"state":71,"zip":72,"country":73,"countryCode":74,"cosmosGeoPoint":75,"geoPoint":80,"contacts":81},"The University of Texas at Austin","RECRUITING","Austin","Texas","78712","United States","US",{"type":76,"coordinates":77},"Point",[78,79],-97.74306,30.26715,{"lat":79,"lon":78},[82,84],{"name":62,"role":63,"phone":64,"phoneExt":16,"email":83},"utbrainproject@gmail.com",{"name":62,"role":85,"phone":16,"phoneExt":16,"email":16},"PRINCIPAL_INVESTIGATOR",{"type":87,"investigatorFullName":88,"investigatorTitle":89,"investigatorAffiliation":5,"oldNameTitle":16,"oldOrganization":16},"SPONSOR_INVESTIGATOR","Francisco Gonzalez-Lima, PhD","Professor; Director, Texas Consortium in Behavioral Neuroscience","100603236",false,"NCT07133893","Transcranial Photobiomodulation in Anxiety Disorders","Effects of Transcranial Photobiomodulation and Attention Bias Modification on Anxiety Symptoms and Brain Hemodynamics","Inclusion Criteria:\n\n* 18 years of age and older\n* State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety)\n* Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression)\n\nExclusion Criteria:\n\n* STAI score less than 40 or greater than 59\n* PHQ-9 score greater than 9\n* Medication instability (i.e., medication change within 6 weeks)\n* Indicated suicidal ideation\n* Currently receiving tPBM treatment\n* Current pregnancy",true,"ALL","18 Years","100 Years",{"count":101,"type":102},280,"ESTIMATED","INTERVENTIONAL",[105],"NA","The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.",[108],"Symptoms of Anxiety",[110,111,112,113],"Photobiomodulation","Sub-clinical anxiety","Near-infrared spectroscopy (NIRS)","attention bias modification","2026-05-11",{"date":116,"type":117},"2026-05-14","ACTUAL",{"date":119,"type":117},"2025-09-01",{"date":121,"type":102},"2028-09",{"name":88,"class":6},1]